Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating AML with PEGylated l-asparaginase

Method of treating AML with PEGylated l-asparaginase

US Patent 12441992 · Granted Oct 14, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pegylated L-asparaginase2023
Heparin-binding domain of IGFBP-2 in the treatment of metabolic disorders2021
PEGylated L-asparaginase2021
Compounds, compositions and uses thereof for improvement of bone disorders2021
PEGylated L-asparaginase2018
Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylat2017
GH secretagogues and uses thereof2013
GH secretagogues and uses thereof2013
GH secretagogues and uses thereof2012
Use of growth hormone releasing factor analogs in treating patients suffering fr2011
GH secretagogues and uses thereof2008
Modified GLP-1 peptides with increased biological potency2006